Analabs Resources Berhad (KLSE:ANALABS) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

ANALABS Panoramica delle azioni

ANALABS analisi fondamentale
Punteggio fiocco di neve
Valutazione	4/6
Crescita futura	0/6
Prestazioni passate	4/6
Salute finanziaria	3/6
Dividendi	2/6

Premi

Negoziato a 50.4% al di sotto della nostra stima del suo valore equo

Gli utili sono cresciuti del 19% nell'ultimo anno

Analisi del rischio

Non ha una capitalizzazione di mercato significativa ( MYR195M )

Analabs Resources Berhad Concorrenti

Hil Industries Berhad

KLSE:HIL

RM 295.4m

Luster Industries Bhd

KLSE:LUSTER

RM 211.6m

DPI Holdings Berhad

KLSE:DPIH

RM 131.4m

Zantat Holdings Berhad

KLSE:ZANTAT

RM 102.2m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Analabs Resources Berhad
Prezzi storici delle azioni
Prezzo attuale dell'azione	RM 1.76
Massimo di 52 settimane	RM 1.86
Minimo di 52 settimane	RM 1.47
Beta	0.44
1Variazione di 1 mese	-1.12%
Variazione a 3 mesi	-3.30%
Variazione di 1 anno	17.33%
3Variazione a 3 anni	49.15%
Variazione a 5 anni	70.87%
Variazione dall'IPO	-29.13%

Notizie e aggiornamenti recenti

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Recent updates

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Feb 13

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Mar 28

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Apr 28

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Apr 07

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Mar 17

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Feb 19

Rendimenti per gli azionisti

	ANALABS	MY Chemicals	MY Mercato
7D	-0.6%	6.0%	1.0%
1Y	17.3%	-11.0%	14.1%

Ritorno vs Industria: ANALABS ha superato il MY Chemicals che ha restituito -14.4 % nell'ultimo anno.

Rendimento vs Mercato: ANALABS ha superato il mercato MY che ha restituito 14.4 % nell'ultimo anno.

Volatilità dei prezzi

Is ANALABS's price volatile compared to industry and market?
ANALABS volatility
ANALABS Average Weekly Movement	4.1%
Chemicals Industry Average Movement	6.6%
Market Average Movement	6.1%
10% most volatile stocks in MY Market	11.4%
10% least volatile stocks in MY Market	2.8%

Prezzo delle azioni stabile: ANALABS non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di ANALABS è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1936	n/a	Mun Kan	www.analabs.com.my

Analabs Resources Berhad, una holding di investimento, produce, formula e vende resine, prodotti chimici e materiali da costruzione in Malesia, nel resto dell'Asia, in Australia e a livello internazionale. Raccoglie, tratta, recupera e ricicla rifiuti industriali e organici e vende prodotti riciclati. Inoltre, è coinvolta nella formulazione e nel riconfezionamento di prodotti chimici per l'agricoltura, nella fornitura di servizi di movimentazione di stoccaggio, in lavori su commissione, nella posa di tubi e in attività di riabilitazione e nella locazione di immobili.

Analabs Resources Berhad Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Analabs Resources Berhad con la sua capitalizzazione di mercato?
ANALABS statistiche fondamentali
Capitalizzazione di mercato	RM 191.72m
Guadagni(TTM)	RM 27.66m
Ricavi(TTM)	RM 152.47m

6.9x

Rapporto P/E

1.3x

Rapporto P/S

ANALABS è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
ANALABS Conto economico (TTM)
Ricavi	RM 152.47m
Costo del fatturato	RM 108.99m
Profitto lordo	RM 43.47m
Altre spese	RM 15.82m
Guadagni	RM 27.66m

Ultimi guadagni dichiarati

Apr 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	0.25
Margine lordo	28.51%
Margine di profitto netto	18.14%
Rapporto debito/patrimonio netto	40.1%

Come si è comportato ANALABS nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.2%

Rendimento attuale del dividendo

8%

Rapporto di remunerazione

ANALABS Panoramica delle azioni

Premi

Analisi del rischio

Analabs Resources Berhad Concorrenti

KLSE:HIL

RM 295.4m

KLSE:LUSTER

RM 211.6m

KLSE:DPIH

RM 131.4m

KLSE:ZANTAT

RM 102.2m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023)

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Upcoming dividend of RM0.021 per share

Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Recent updates

Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023)

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Upcoming dividend of RM0.021 per share

Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New major risk - Financial position

Analabs Resources Berhad Reports Write Offs for the Quarter Ended October 31, 2023

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2024

Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.012 (vs RM0.098 in 3Q 2022)

Upcoming dividend of RM0.02 per share at 1.4% yield

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2023, Payable on 10 March 2023

Second quarter 2023 earnings released: EPS: RM0.051 (vs RM0.063 in 2Q 2022)

Analabs Resources Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 April 2023

Analabs Resources Berhad Announces Cessation of Office of Mr. Lai Yew Choong as Independent and Non Executive Member of Risk Committee

Insufficient new directors

Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Member of Audit Committee

Full year 2022 earnings released: EPS: RM0.27 (vs RM0.15 in FY 2021)

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Director

Analabs Resources Berhad Re-Designates Kan Mun Hoow as Chief Executive Officer, Effective from 1 April 2022

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings released: EPS: RM0.098 (vs RM0.051 in 3Q 2021)

Upcoming dividend of RM0.02 per share

Analabs Resources Berhad Announces Single-Tier Interim Dividend for the Period Ending April 30, 2022, Payable on March 11, 2022

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Full year 2021 earnings released: EPS RM0.15 (vs RM0.067 in FY 2020)

Full year 2021 earnings released

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Third quarter 2021 earnings released: EPS RM0.051 (vs RM0.012 in 3Q 2020)

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

New 90-day low: RM1.10

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New 90-day high: RM1.19

Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Second quarter 2021 earnings released: EPS RM0.022

Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

New 90-day high: RM1.22

Analabs Resources Berhad Announces the Resignation of TAN AI PENG as Company Secretary

First quarter earnings released

Full year earnings released - EPS RM0.067

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

Analabs Resources Berhad Riepilogo dei fondamenti

6.9x

1.3x

Guadagni e ricavi

Dividendi